Why the study?
Do xanthine drugs (theobromine and theophylline) cause coronary vasodilation and improve symptoms in patients with angina pectoris?
Do xanthine drugs (theobromine and theophylline) cause coronary vasodilation and improve symptoms in patients with angina pectoris?
Xanthine drugs demonstrate potent coronary vasodilatory properties in experimental models and may be effective in treating angina pectoris.
Answers are grounded in this paper and cite their sources.
Xanthine drugs may merit reevaluation in angina; leaves open confirmation in contemporary randomized trials.
There is abundant experimental proof that the xanthines theobromine and theophylline, as well as other members of the series, are potent vasodilators of the coronary arteries. These drugs have been shown to possess this property in human1and canine2heart-lung preparations: in the intact anesthetized dog by measuring the outflow from the coronary sinus,3and in the intact anesthetized and trained conscious dog by using a thermostromuhr4on one or another of the coronary arteries. Levy and his associates5have demonstrated this property of the xanthines inferentially and reported the favorable influence of these drugs on patients with attacks of angina pectoris induced by breathing an atmosphere containing only 10 per cent oxygen. In a recent report Gilbert, Fenn and LeRoy6have confirmed this observation. Experiments soon to be published by Gilbert and me demonstrate that the mortality after experimental occlusion of the coronary
No takes yet. Share an insight, caveat, or question.
G. Leroy (1941) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: